Consumers, influencers, and lawmakers are driving a generational evolution in health policy areas. We help clients position ahead of the changes.
We advise health and life sciences companies and organizations on the federal policy and regulatory frameworks shaping reimbursement, pricing, innovation, and patient access. We’re also engaging directly on the nationwide food and healthfulness debates. Our work includes direct engagement with Congress, HHS, FDA, CMS, and USDA on issues central to these areas.
Federal efforts to increase transparency and oversight in pharmacy benefit management are advancing on multiple tracks. We advise clients on rebate reform, pricing model changes, and the competitive dynamics shifting as legislation and rulemaking evolve
BARDA/ASPR funding, pandemic preparedness policy, and biodefense procurement present strategic and commercial opportunities. We help clients align with federal priorities and engage on program development, funding decisions, and legislative initiatives.
VA healthcare policy and procurement decisions affect a significant segment of the healthcare market. We provide strategic guidance on policy developments, budget decisions, and advocacy opportunities affecting delivery of care to veterans.
The MAHA movement sweeping the nation is driving changes in agricultural policies, vaccine requirements, nutrition standards, and more. Our connections provide clients with invaluable access to the decisionmakers in these spaces.